Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Advanced Radiotherapy Techniques, and Meningioma and schwannoma management.
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma
Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases
Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases
Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base
Hemorrhagic and Cystic Brain Metastases Are Associated With an Increased Risk of Leptomeningeal Dissemination After Surgical Resection and Adjuvant Stereotactic Radiosurgery
Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis
Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high‐risk grade 2 glioma: An analysis of the National Cancer Data Base
Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis
Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases
Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases
Novel risk stratification score for predicting early distant brain failure and salvage whole‐brain radiotherapy after stereotactic radiosurgery for brain metastases
Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone
Bevacizumab‐induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab
Primary CNS Natural Killer/T-Cell Lymphoma of the Nasal Type Presenting in a Woman: Case Report and Review of the Literature
The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma
Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation
Current Dosing Paradigm for Stereotactic Radiosurgery Alone After Surgical Resection of Brain Metastases Needs to Be Optimized for Improved Local Control
Six degrees of freedom CBCT‐based positioning for intracranial targets treated with frameless stereotactic radiosurgery
Clinical outcomes of radiotherapy as initial local therapy for Graves’ ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery